Malignant Neoplasm of Stomach Recruiting Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02903914Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsTreatment
NCT02901301Pembrolizumab, Trastuzumab, HER2 Positive Gastric CancerTreatment
NCT02393248Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Treatment